ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 186

Paediatric Musculoskeletal (MSK) Triage in the Community – Rightpath – a Pilot Study

Nicola Smith1, Sharmila Jandial2, Jill Firth3, Helen Light3, Katharine Kinsey3, Neil Snowden3, Judith McNaught4, Tim Rapley5, Alan Nye3 and Helen E. Foster6, 1Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, 2Paediatric Rheumatology, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom, 3Pennine MSK Partnership Ltd, Oldham, United Kingdom, 4Physiotherapy, South Tyneside NHS Foundation Trust, South Shields, United Kingdom, 5Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, United Kingdom, 6Institute of Cellular Medicine and Paediatric Rheumatology, Newcastle University and Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Access to care, Clinical practice, pediatrics and primary care, Triage

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Health Services Research Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

We are piloting a children and young people (CYP) community-based triage (called Rightpath) based on a validated adult MSK triage model developed by Pennine MSK Partnership Ltd (PMSKP), Greater Manchester. Rightpath aims to promptly identify CYP with MSK pathology and triage them to the appropriate service (rheumatology, orthopaedics, neurodisability or urgent care), and to manage those who do not need specialist referral appropriately within the community. Triage and referral guidance has been developed in partnership with MSK specialists and this study aims to test its safety, feasibility and acceptability in the community, and through application across two geographical areas in the UK to assess transferability.

Methods:

Piloted first at PMSKP, with iteration of the triage guidance and process followed by roll out at a second site (South Tyneside NHS Trust). Using mixed methods, evaluation focused on key areas:

Implementation – workshops with service providers (triagers and clinicians) held at two time points to refine triage guidance and process.

Training – for triagers based on their weekly log of triage experiences and regular case based discussions and feedback.

Evaluation – (i) Parent/ patient questionnaire, incorporating the ‘Friends and Family’ test and ‘Collaborate’ (a patient reported measure of shared decision-making), completed immediately after consultation to explore expectations and satisfaction; (ii) Service providers weekly log documenting experiences and training needs; (iii) Routine patient data including demographic details, referral information, triage outcome, ultimate diagnosis/outcome and communication between triage teams and health care providers; (iv) Service providers signposted to key areas for self-directed learning (paediatric musculoskeletal matters [PMM] – www.pmmonline.org) and usage monitored.

This study had ethical approval.

Results:

Total triaged 05/09/16 – 30/04/17 (101 to Rightpath, 264 to specialist paediatric services). The most common CYP MSK referrals from the community were knee pain, foot pain, flat feet and back pain; the most common conditions triaged to Rightpath were foot pain, knee pain, flat feet, and in-toeing. No significant pathology has been triaged inappropriately so far to Rightpath. Feedback from 66 Rightpath family participants was positive (no complaints or requests for onward specialist referral); 100% would recommend the service, with satisfaction (1-10) scores about community providers being high (1=’no’ and 9=’every’ effort made); ‘helped understand your/your child’s health issues’ (8.9), ‘listened to things that matter most to you about your/your child’s health’ (8.9), ‘included what matters most to you in choosing what to do next’ (8.9). Community therapists and podiatry described the clinical workload to be appropriate for their existing skills. Triage staff deemed the triage process manageable (57% of decisions ‘easy/very easy’) and triage guidance to be useful commenting that paediatric experience was important to support decision-making.

Conclusion:

Initial data shows Rightpath to be feasible, safe and acceptable. Phase 2 of the pilot is in progress at the second site.


Disclosure: N. Smith, None; S. Jandial, None; J. Firth, None; H. Light, None; K. Kinsey, None; N. Snowden, None; J. McNaught, None; T. Rapley, None; A. Nye, None; H. E. Foster, None.

To cite this abstract in AMA style:

Smith N, Jandial S, Firth J, Light H, Kinsey K, Snowden N, McNaught J, Rapley T, Nye A, Foster HE. Paediatric Musculoskeletal (MSK) Triage in the Community – Rightpath – a Pilot Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/paediatric-musculoskeletal-msk-triage-in-the-community-rightpath-a-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/paediatric-musculoskeletal-msk-triage-in-the-community-rightpath-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology